Evaluation of homologous recombination deficiency (HRD) score and immuno-tumor microenvironment (iTME) as biomarkers of soft tissue sarcoma (STS) survival and response to immune checkpoint inhibitor therapy.
Chenlu Zhang(Northwestern University), Yuhong Zhou(Sun Yat-sen University), Yang You(East China University of Science and Technology), Fei Xu(GenomiCare (China)), Jun Liu(Sichuan University), Zhiming Wang(Guangzhou University of Chinese Medicine), Yong Zhang(Lanzhou University), Lijie Ma(Shanghai Public Health Clinical Center), Wenshuai Liu(Zhongshan Hospital), Hanxing Tong(Sun Yat-sen University), Xi Guo(Zhongshan Hospital), Rongyuan Zhuang(Zhongshan Hospital), Weiqi Lu(Fudan University Shanghai Cancer Center)
Cited by 0
Related Papers
Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974
|Proceedings of the National Academy of Sciences|2013|833
Nuclear Receptor-Dependent Bile Acid Signaling Is Required for Normal Liver Regeneration
|Science|2006|635
Camrelizumab in Combination with Apatinib in Patients with Advanced Hepatocellular Carcinoma (RESCUE): A Nonrandomized, Open-label, Phase II Trial
|Clinical Cancer Research|2020|576
Complete Surgical Excision Is Essential for the Management of Patients With Breast Implant–Associated Anaplastic Large-Cell Lymphoma
|Journal of Clinical Oncology|2015|418